• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗溃疡药物与胃质子泵的相互作用。

Interaction of anti-ulcer drugs with the gastric proton pump.

作者信息

Saccomani G, Hersey S J

机构信息

Department of Physiology and Biophysics, University of Alabama, Birmingham 35294.

出版信息

Drug Metabol Drug Interact. 1989;7(2-3):161-89. doi: 10.1515/dmdi.1989.7.2-3.161.

DOI:10.1515/dmdi.1989.7.2-3.161
PMID:2560952
Abstract

In this review consideration is given to anti-ulcer drugs interaction with the gastric H(+)-K+ ATPase. The review has been divided into three sections. First, properties of the gastric proton pump are described in terms of structure, biological activity and ions transport activity, followed by an account of interactions involving antisecretory agents. Emphasis is given to a new class of drugs (substituted benzimidazole) that shows a unique antisecretory action and is safe and effective for short-term treatment of patients with duodenal or gastric ulcers. The final section briefly examines future directions for the production of more selective inhibitors of the gastric proton pump.

摘要

本综述探讨了抗溃疡药物与胃H(+)-K+ ATP酶的相互作用。该综述分为三个部分。首先,从结构、生物活性和离子转运活性方面描述了胃质子泵的特性,接着阐述了涉及抗分泌药物的相互作用。重点介绍了一类新型药物(取代苯并咪唑),它具有独特的抗分泌作用,对十二指肠溃疡或胃溃疡患者的短期治疗安全有效。最后一部分简要探讨了生产更具选择性的胃质子泵抑制剂的未来方向。

相似文献

1
Interaction of anti-ulcer drugs with the gastric proton pump.抗溃疡药物与胃质子泵的相互作用。
Drug Metabol Drug Interact. 1989;7(2-3):161-89. doi: 10.1515/dmdi.1989.7.2-3.161.
2
[Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].[胃质子泵抑制剂对胃酸分泌及消化性溃疡的影响]
Nihon Yakurigaku Zasshi. 1986 Apr;87(4):351-60. doi: 10.1254/fpj.87.351.
3
Gastric H,K-ATPase as therapeutic target.胃H,K-ATP酶作为治疗靶点。
Annu Rev Pharmacol Toxicol. 1988;28:269-84. doi: 10.1146/annurev.pa.28.040188.001413.
4
[Discovery and development of the proton pump inhibitor].[质子泵抑制剂的发现与研发]
Nihon Rinsho. 1992 Jan;50(1):11-7.
5
Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.新型质子泵抑制剂AG-1749在犬和大鼠中的抗分泌及抗溃疡活性
J Pharmacol Exp Ther. 1989 Feb;248(2):806-15.
6
Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.通过抑制胃H⁺,K⁺-ATP酶治疗酸相关性疾病。
Annu Rev Med. 1986;37:97-105. doi: 10.1146/annurev.me.37.020186.000525.
7
Antiulcer agents. 5. Inhibition of gastric H+/K(+)-ATPase by substituted imidazo[1,2-a]pyridines and related analogues and its implication in modeling the high affinity potassium ion binding site of the gastric proton pump enzyme.
J Med Chem. 1991 Feb;34(2):533-41. doi: 10.1021/jm00106a008.
8
Biochemical and pharmacological analysis of 2-[(2-dimethylaminobenzyl)sulfinyl] benzimidazole (NC-1300), a new proton pump inhibitor.新型质子泵抑制剂2-[(2-二甲基氨基苄基)亚磺酰基]苯并咪唑(NC-1300)的生化与药理学分析
Jpn J Pharmacol. 1986 Feb;40(2):239-49. doi: 10.1254/jjp.40.239.
9
[Protective effect of proton pump inhibitor on the gastric mucosa].[质子泵抑制剂对胃黏膜的保护作用]
Nihon Rinsho. 1992 Jan;50(1):33-8.
10
Inhibition of gastric H+,K(+)-ATPase by the anti-ulcer agent, sofalcone.
Biochem Pharmacol. 1991 Sep 12;42(7):1447-51. doi: 10.1016/0006-2952(91)90458-h.